12d
Hosted on MSNModerna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week HighShares of Moderna Inc. climbed nearly 1% on Friday, reaching levels last seen on Jan. 10, as retail sentiment turned ...
12d
Investor's Business Daily on MSNModerna Yo-Yos After European Officials Ink Supply Deal For Covid ShotsModerna won an agreement for its Covid vaccines in Europe on Friday, but Moderna stock reversed its early gains.
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...
In September 2024, the European Commission (EC) granted marketing authorization for an updated formulation of Moderna's COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results